Bill Schief

Researcher at Scripps Research Institute and vice president of protein design at Moderna, presented strategies for an HIV vaccine inducing broadly neutralizing antibodies.

Amburgo ospita la Conferenza Europea sulla Terapia Genica 2026 con focus su sicurezza e progressi nel vaccino contro l'HIV